ANN ARBOR, Mich., Jan. 27, 2012 — /PRNewswire/ – Everist Genomics uttered now that Executive Vice Chairman Alex Charlton will verbalize about a ultimate thing CardioDefender Device during a Wearable Technologies Conference, Jan 30, 2012, in Munich.
(Photo: http://photos.prnewswire.com/prnh/20120127/NY42940 )
(Logo: http://photos.prnewswire.com/prnh/20110110/NY26865LOGO )
Smartphone medical applications have been graduating from newness apparatus to mainstream medicine, aiding physicians to save lives as good as devaluate a cost of care. Everist Genomics, a quick multiplying personalized disinfectant company, is successfully integrating smartphone as good as marker resource record with innovative, medically vicious diagnostics as good as prognostics in a areas of cardiovascular disease, metabolic mould (e.g. diabetes) as good as cancer. Everist Genomics’ CardioDefender is a world’s initial FDA-approved as good as CE mark-registered smartphone ECG element to produce physicians as good as patients with hospital-quality heart cadence monitoring external of a home setting. CardioDefender incorporates manifold unaccompanied capabilities enabling physicians to diagnose as good as produce potentially life-threatening heart arrhythmias that cunning differently be missed. CardioDefender is a initial element to present mobile, real-time, beat-by-beat, as good as quantitative heart monitoring as good as automatic saying by blending law process smartphone module with a Wi-Fi device as good as electrodes.
“The spirit of personalized disinfectant is to diagnose a censure before to there have been celebrated symptoms. Physicians who diagnose as good as produce heart arrhythmias have been hampered for many years by leave technology, such as home shaped ECG systems that hinder patients to a high-cost home sourroundings as good as Holter monitors that do not produce a endless monitoring indispensable to acknowledge potentially reason adult unhappy arrhythmias,” Charlton said. “For a initial time, CardioDefender enables smartphone-based hospital-quality ECG monitoring of patients twenty-four hours per day, 7 days per week.”
The company’s not prolonged ago uttered commercialization skeleton of CardioDefender occur during a same time with reports from assorted courtesy sources lifted touching enlargement in remote careful monitoring. According to researcher organization Berg Insight, for example, around 2.2 million patients worldwide were controlling home monitoring work shaped on apparatus with integrated connectivity during a finish of 2011—cardiac arrhythmia was cited as one of a many common conditions monitored by these technologies.(1)
Following FDA defeat as good as European CE Mark registration final year, CardioDefender has already been deployed during some-more than 150 recovering amenities in a United States for post-approval content evaluation. Between Jan as good as Oct of 2011, a array of careful days of heart cadence monitoring achieved with CardioDefender grew from fewer than 5,000 to some-more than 18,000 careful days per month. Since a element was introduced, Everist Genomics has viewed inquiries about a product from some-more than 32 countries, together with China, India as good as a U.S.
“We have been unequivocally appreciative with a success of a content research of CardioDefender as good as a eager spin of charisma we have viewed per a accessibility of a justification system,” Charlton said. “The call in to verbalize during a highly-esteemed Wearable Technologies Conference offer underscores a value of this innovative mobile element in some-more modernized caring for arrhythmia patients.”
Everist Genomics launched a initial product final year with a pivotal of OncoDefender-CRC, a premonitory examination for prescient a risk of mould rule for early entertainment colorectal cancer patients. The organisation stretched a tube with a fad of a ultimate authorisation of justification as good as premonitory tests destined during melding personalized disinfectant with mobile illness platforms. In serve to a CardioDefender justification system, Everist Genomics not prolonged ago uttered expansion of AngioDefender, a world’s initial marker resource device means of sincerely diagnosing atherosclerosis in asymptomatic patients. The organisation is building mobile applications for a AngioDefender element to increase medicine opening to vicious careful news as good as produce clinical wait for diagnosis planning. The organisation skeleton to launch a AngioDefender element in Feb 2012.
About Everist Genomics
Everist Genomics is a prognostics organisation focused on building gene-based molecular assays for a anticipation of cancer rule as good as disdainful point-of-care apparatus for a research as good as supervision of cardiovascular disease. Using a law Evolver™ record platform, Everist Genomics is successfully building as good as commercializing unconditionally ultimate classes of patent-protected molecular biomarkers as good as sensor technologies that occupy disdainful equipment, desire as good as module to assistance physicians have individualized diagnosis as good as drug prescribing decisions. The personally owned organisation is located in Ann Arbor, Michigan. For some-more information, greatfully visit www.everistgenomics.com.
About The Wearable Technologies Conference
On Jan 30, 2012, for a fifth time in a row, a Wearable Technologies Conference will take place in line with ISPO in Munich. This stimulating conference, sponsored by Philips, offers courtesy leaders from vicious companies such as Roche as good as Adidas, as good as rising companies, a unaccompanied tallness to donation their ultimate innovations from a domain of healthcare.
This year’s contention will underline twin areas of interest, namely a newest developments in a areas of “Sports Consumers” as good as “Health Fitness.” In serve to novel technologies in development, a 2012 WTconference will donation products prepared for market. These days, technologies husky on or circuitously a physique have been experiencing a genuine boom. The initial WT products, those enchanting to a wider market, have been recording resounding successes. In addition, a many innovative technologies that have usually reached a marketplace entertainment have spin all a some-more vicious to those manufacturers who can work a ultimate technologies in a accumulation of their products.
More news on a contention can be found during www.wearable-technologies.com/wt-conference.
(1) http://www.berginsight.com/News.aspx?m_m=6s_m=1
SOURCE Everist Genomics
{ 0 comments… add one now }
Leave a Comment